Skip to main navigation Skip to search Skip to main content

Development of a reference and proficiency chemical list for human steatosis endpoints in vitro

Research output: Contribution to journalReview articlepeer-review

9 Citations (Scopus)

Abstract

The most prevalent liver disease in humans is non-alcoholic fatty liver disease, characterised by excessive hepatic fat accumulation, or steatosis. The western diet and a sedentary lifestyle are considered to be major influences, but chemical exposure may also play a role. Suspected environmental chemicals of concern include pesticides, plasticizers, metals, and perfluorinated compounds. Here we present a detailed literature analysis of chemicals that may (or may not) be implicated in lipid accumulation in the liver, to provide a basis for developing and optimizing human steatosis-relevant in vitro test methods. Independently collated and reviewed reference and proficiency chemicals are needed to assist in the test method development where an assay is intended to ultimately be taken forward for OECD Test Guideline development purposes. The selection criteria and considerations required for acceptance of proficiency chemical selection for OECD Test Guideline development. (i.e., structural diversity, range of activity including negatives, relevant chemical sectors, global restrictions, etc.) is described herein. Of 160 chemicals initially screened for inclusion, 36 were prioritized for detailed review. Based on the selection criteria and a weight-of-evidence basis, 18 chemicals (9 steatosis inducers, 9 negatives), including some environmental chemicals of concern, were ranked as high priority chemicals to assist in vitro human steatosis test method optimisation and proficiency testing, and inform potential subsequent test method (pre-)validation.

Original languageEnglish
Article number1126880
JournalFrontiers in Endocrinology
Volume14
DOIs
Publication statusPublished - 2023

Bibliographical note

Funding Information:
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825489 (“GOLIATH”). This output reflects only the authors’ views and the European Union’s Research Executive Agency and the European Commission are not responsible for any use that may be made of the information it contains. Acknowledgments

Funding Information:
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825489 (“GOLIATH”). This output reflects only the authors’ views and the European Union’s Research Executive Agency and the European Commission are not responsible for any use that may be made of the information it contains.

Publisher Copyright:
Copyright © 2023 Kubickova and Jacobs.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • HepaRG
  • alternative method
  • drug-induced liver injury
  • human hazard
  • lipid accumulation
  • new approach methodology
  • triglyceride
  • validation

Fingerprint

Dive into the research topics of 'Development of a reference and proficiency chemical list for human steatosis endpoints in vitro'. Together they form a unique fingerprint.

Cite this